In vitro activity of ceftobiprole and dalbavancin against a collection of coagulase-negative staphylococci isolates from clinical samples with reduced susceptibility to daptomycin and/or resistant to linezolid or glycopeptides Silvia Velasco de la Fuente; Marta Fernández-Martinez; Jesús Rodríguez Lozano; Daniel Pablo-Marcos; María Siller; Jorge Calvo Montes;

Addressing catheter lock therapy: Does heparin reduce the bioactivity of dalbavancin when together in solution during freezing? Marta Díaz-Navarro; Rama Hafian; María Jesús Pérez-Granda; Emilia Cercenado; Patricia Muñoz; María Guembe;

Dalbavancin as sequential therapy in infective endocarditis: Real-life experience in elder and comorbid patients Eduardo Aparicio-Minguijón; Jorge Boán; Antonio Terrón; Carlos Heredia; Cristina Puente; Asunción Pérez-Jacoiste Asín; M. Ángeles Orellana; Laura Domínguez; José Manuel Caro; M. Jesús López-Gude; Eva María Aguilar-Blanco; Andrea Eixerés-Esteve; Francisco López-Medrano;